Quest Diagnostics Incorporated
DGX
Pozycja w akcjach
#934
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Cena akcji
$234.71
Ostatnia synchronizacja: 2026-10-16
Kapitalizacja rynkowa
$25.91B
Zmiana (1 dzień)
-1.76%
Zmiana (1 rok)
23.85%
Kraj
US
Handel Quest Diagnostics Incorporated (DGX)
Kategoria
Healthcare
Marża operacyjna dla Quest Diagnostics Incorporated (DGX)
Marża operacyjna na dzień October 2026 TTM: 14.14%
Według najnowszych raportów finansowych i ceny akcji Quest Diagnostics Incorporated, bieżąca marża operacyjna (TTM) wynosi 14.14%. Na koniec 2024 wynosiła 13.63%.
Historia marży operacyjnej dla Quest Diagnostics Incorporated od 2000 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2026 (TTM) | 14.14% | -2.68% |
| 2025 | 14.53% | 6.60% |
| 2024 | 13.63% | -0.07% |
| 2023 | 13.64% | -5.61% |
| 2022 | 14.45% | -34.53% |
| 2021 | 22.07% | 5.65% |
| 2020 | 20.89% | 31.14% |
| 2019 | 15.93% | 8.96% |
| 2018 | 14.62% | -3.24% |
| 2017 | 15.11% | -11.07% |
| 2016 | 16.99% | -9.00% |
| 2015 | 18.67% | 41.23% |
| 2014 | 13.22% | -35.95% |
| 2013 | 20.64% | 26.86% |
| 2012 | 16.27% | 22.79% |
| 2011 | 13.25% | -24.63% |
| 2010 | 17.58% | -3.57% |
| 2009 | 18.23% | 8.13% |
| 2008 | 16.86% | 3.56% |
| 2007 | 16.28% | -9.51% |
| 2006 | 17.99% | 2.27% |
| 2005 | 17.59% | 0.06% |
| 2004 | 17.58% | 4.71% |
| 2003 | 16.79% | 16.44% |
| 2002 | 14.42% | 27.16% |
| 2001 | 11.34% | 22.07% |
| 2000 | 9.29% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 17.97% | -98.73% |
US
|
|
| 20.42% | -98.56% |
US
|
|
| -10.70% | -100.76% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -98.43% |
US
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.